chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had severe chills and sore throat and the next day on 02/19/2023, I took the test, It was positive. I contacted my doctor via telephone. On that next day I had a slight fever, cough and fatigue. It left a metallic taste that was unpleasant. He prescribed me Paxlovid. About three days or so I felt better after it is taking the Paxlovid.
urticaria developed 7/16. pt seen in clinic 7/17 and Tx with Benadryl
2 days after administration of vaccine started with fever, SOB, Nausea and vomiting and swelling at site
Arm stiffness and pain, swelling, low grade fever, fatigue (going on 2 days as of now) Using Tylenol for symptoms
11/27/21 presents to ED for "dry cough" "mild fatigue, diaphoresis, mild sob and loss of taste". PMHx of "DM II, CAD s/p CABG, anemia, HTN, CVA, and ESRD s/p renal transplant"
On May 20, 1999 the pt developed a fever of 102F. The MD advised the pt's mother to give the pt acetaminophen.
This spontaneous report as received from a medical assistant refers to a 61 year old female patient. On 19-SEP-2014 the patient was intramuscularly vaccinated with ZOSTAVAX (in the left arm, 0.65 ml, lot # K000727, expiration date: 30-JAN-2015) instead of subcutaneously. On 19-SEP-2014, reported as immediately afterward, another 0.65 ml dose of ZOSTAVAX (0.65 ml, lot # K000727, expiration date: 30-JAN-2015) was administered subcutaneously, in the same left arm, at a different site. No adverse effects reported at that time. Additional information has been requested.
Narrative:  Patient developed high blood pressure for at least 5 days after receiving 2nd dose of pfizer vaccine, verified at unit visit. BPs are significantly elevated. Pt with no prior history of significant HTN.
Moderna vaccine given without incidence, waited 15 minutes after vaccine without incidence. Client returned to the health department at 11:50AM stating she started having some symptoms at approximately 11:40AM. She reported the following symptoms- Stated feeling funny, ears hot "burning", face "breaking out" and "itchy", mouth burning a little. Upon observation ears were reddened and a few small reddened areas on face. Client was observed for an additional 30 minutes without any change in symptoms or complaints. Instructed her to contact her primary care physician regarding her immunization. Client arrived at her home around 12:30-1:00pm. Dis not take any medication at that time. Stated symptoms were going away. Around 2:00pm she stated she had a runny nose, mild sore throat, headache, sore arm, body aches. Denies any burning or rashes. Symptoms continued thru 1/6/21. States she took 3 ibuprofen at 11:00am on 1/6/21.  Client had not contacted PCP at that time. Client was once again instructed to contact her PCP regarding her immunization. Attempted to contact on 1/8, 1/11, 1/13, 1/15 and 1/23 without any success "mailbox full". Per conversation on 2/2/21 states "everything was gone on 1/7/21.
Starting from the day of the vaccine,  I did not have any side effects.  About 2 days after, I started to notice tingling in my throat and difficulty breathing.  I could see my throat was swollen and started to close up.  I went to doctor's office and they prescribed me antibiotics (amoxicillin) and steroids (methylprednisone).  I took the medications but the tonsils are still swollen. At this time, I decided to go to ENT specialist.  I was then diagnosed with Mono.
9/15/99 fever, redness & swelling of lt deltoid, h/a;
A report has been received from a Health Professional concerning a 7 year old, Male subject, who had been receiving FLUMIST quadrivalent (intranasal), 0.2 milliliters, Once/Single administration. FLUMIST quadrivalent started on 12-Jan-2015. The nurse administered expired FLUMIST quadrivalent to a patient. The patient recovered from the event of inadvertently administered expired FLUMIST quadrivalent to a patient on an unspecified date. The report was considered to be non-serious by the reporter.
Pt had severe soreness at injection site immediately. It was still hurting 1 week later. No redness or mark.
Patient developed edema around mouth and eyes after vaccines given. Also had eye pain and hives appearing around mouth. Given epinephrine 0.15ml (1:1000) and Benadryl 2.5mg after symptoms appeared with improvement of symptoms in one minute. Date of vaccination and adverse event was 03/08/2004.
While in waiting room after immunizations, mom reported seeing client twitching with arms pulled close to body. Pt fell on the floor and hit head on wall. Client lost control of bladder. When RN arrived on scene. Client was conscious, HR stable. Client remained in sitting position for 5 min before walking out of office. Gave client some fruit juice. c/o neck/back pain
Unauthorized aged group received vaccine; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Unauthorized aged group received vaccine) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Unauthorized aged group received vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Unauthorized aged group received vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment information were provided   Reporter did not allow further contact
Provider ordered Varicella  RN administered Shingrex  Provider and pt notified.   Awaiting ID consult to advise on next steps
Severe heart pain, short breath, palpitations, arm pain, lastin 36 hrs. Followed by intermittent palpitations, arm pain, over the next few weeks, still actively occurring.
Patient came to pharmacy days after vaccine was given - stated she had numbness/tingling on outside of her right hand (from wrist to small finger) that felt as if her had was about to "fall asleep". It started during administration and lasted till today. Will follow up with her next week. Has not gotten worse/stayed the same.
Rash on both sides of my underarms near my armpits. NOTE: This is not debilitating in any way.
ADMINISTRATION ERROR : Pt. received the 1st dose of Moderna 09/10/2021 then received the 2nd dose of Phizer 10/07/2021. No noted symptoms nor Primary visit.
Approximately 02/01/2023, I had cold symptoms, was run down, could not go to church. I was out of commission.  I had body aches from typical cold symptoms for three to five days. I went to an urgent care clinic.
He had fever/fever was 103-104/Fever came down after 5 to 6 hours but came back again/As of now, he still has fever; He had chills on friday; He also had body aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (He had fever/fever was 103-104/Fever came down after 5 to 6 hours but came back again/As of now, he still has fever), CHILLS (He had chills on friday) and MYALGIA (He also had body aches) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included QUINAPRIL, AMLODIPINE, METOPROLOL, ATORVASTATIN, METFORMIN and OMEPRAZOLE for an unknown indication.    On 03-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Aug-2021, the patient experienced PYREXIA (He had fever/fever was 103-104/Fever came down after 5 to 6 hours but came back again/As of now, he still has fever), CHILLS (He had chills on friday) and MYALGIA (He also had body aches). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, PYREXIA (He had fever/fever was 103-104/Fever came down after 5 to 6 hours but came back again/As of now, he still has fever) had not resolved and CHILLS (He had chills on friday) and MYALGIA (He also had body aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Aug-2021, Pyrexia: 103-104 (High) 103-104.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Intrauterine fetal demise at 39 weeks and 4 days (? cord accident)
Information has been received from a physician concerning a patient who was vaccinated with Zostavax (Oka/Merck) and one week later developed chickenpox.  Unspecified medical attention was sought.  There was no product quality complaint.  Additional information has been requested.
has a lot of phlegm when she coughs; has a lot of phlegm when she coughs; tested positive for Covid; tested positive for Covid; not feeling well; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 46-year-old female patient received BNT162b2 (BNT162B2), on 20Mar2021 as dose 1, single (Lot number: ER8730), on 10Apr2021 as dose 2, single (Lot number: EP7553) and on 18Oct2021 as dose 3 (booster), single (Lot number: FF2587) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious) with onset 14Jun2022, outcome "unknown", described as "not feeling well"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 16Jun2022, outcome "unknown" and all described as "tested positive for Covid"; COUGH (non-serious), PRODUCTIVE COUGH (non-serious), outcome "unknown" and all described as "has a lot of phlegm when she coughs". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (14Jun2022) Negative, notes: Started not feeling well Tuesday 16Jun2022, tested negative; (16Jun2022) Positive, notes: Tested positive this morning,16Jun2022. The reporter's friend tested positive for Covid today Pfizer Covid Vaccine. Symptoms: Started not feeling well Tuesday 14Jun2022, tested negative. The patient tested positive this morning, 16Jun2022. She felt terrible. No fever was reported.
After receiving the shot, my daughter fainted in the car as we were leaving the doctor's office. We immediately returned to the office and they observed her for a few minutes. She has never fainted prior to this event. We are now 7 weeks later and she had another fainting spell.
COVID-19 virus test positive/COVID-19/Rhinorrhea/Throat irritation; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19 virus test positive/COVID-19/Rhinorrhea/Throat irritation) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-May-2022 at 3:00 PM, the patient experienced COVID-19 (COVID-19 virus test positive/COVID-19/Rhinorrhea/Throat irritation). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 18-May-2022 to 23-May-2022 for COVID-19, at an unspecified dose and frequency. At the time of the report, COVID-19 (COVID-19 virus test positive/COVID-19/Rhinorrhea/Throat irritation) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-May-2022, SARS-CoV-2 test: tested negative one time (Negative) Tested negative one time. On 27-May-2022, SARS-CoV-2 test: strong positives (Positive) Strong positives. On an unknown date, SARS-CoV-2 test: tested negative three times on at home test (Negative) Tested negative three times on at home test, tested negative three times on at home test (Negative) Tested negative three times on at home test and tested negative three times on at home test (Negative) Tested negative three times on at home test.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient previously received a COVID-19 Vaccine.  The indication for Paxlovid was reported as Treatment of COVID-19.  Company Comment: This spontaneous case concerns a 62-year-old male patient, with no medical history reported, who experienced the unexpected AESI of COVID-19. The event occurred approximately 42 days after receiving the fourth dose of mRNA-1273 Vaccine. The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) for 5 days, however 4 days later, the patient had tested positive again for COVID-19. The outcome of the event was reported as unknown. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a 62-year-old male patient, with no medical history reported, who experienced the unexpected AESI of COVID-19. The event occurred approximately 42 days after receiving the fourth dose of mRNA-1273 Vaccine. The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) for 5 days, however 4 days later, the patient had tested positive again for COVID-19. The outcome of the event was reported as unknown. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
left upper arm redness and swelling 2 weeks after 1st covid vaccine. sx continue to progressively worsen within the past 24 hours of onset otc acetaminophen given with improvement in pain patient prescribed triamcinolone cream and cephalexin
patient developed cough on 7/26/2021, tested positive for COVID on 7/29/2021
Two blood clots in my right calf that travelled up to my lungs; Shortness of breath; Pain in my right calf; Had difficulty just walking; This is a spontaneous report from a contactable consumer (patient). A 73-years-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration in left arm on 12Feb2021 19:30 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. Medical history included heart (as reported) and known allergies to penicillin. There concomitant medications were not reported. On 15Feb2021 18:30 the patient experienced two blood clots in my right calf that travelled up to my lungs, shortness of breath, pain in my right calf, had difficulty just walking. It was reported that two nights after receiving the vaccine, she suffered shortness of breath and pain in her right calf. She tried to relax the next day, but had difficulty just walking. She went to a walk in medical facility. They sent her to the ER. After testing they found that she had two blood clots in her right calf that travelled up to my lungs. The event two blood clots in my right calf that travelled up to my lungs was considered as serious (hospitalization) and other event were considered as serious (hospitalization). The patient was hospitalized for all events for 4 days. The patient underwent lab tests and procedures which included blood test on 15Feb2021 with showed two blood clots in my right calf that travelled up to my lungs and sars-cov-2 test with negative results on Feb2021.Therapeutic measures were taken as a result of two blood clots in my right calf that travelled up to my lungs, shortness of breath, pain in my right calf and had difficulty just walking. AE treatment included blood thinner. The outcome of the events was recovering. No other vaccine was given to patient in four weeks and two weeks. No Covid prior vaccination. If Covid tested post vaccination: Yes. Patient was covid tested post vaccination in Feb2021 with negative results. AE resulted in: [Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization]. Facility type vaccine was Public Health Clinic facility.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Pt came on 9/10/20 and informed the pharmacist that her arm was a little red. He asked her to observe it for 1 more day and report it to the pharmacist on duty if it isn't any better. She came back on 9/11/20 and told me that it was still itching and red.
6 hours after vaccine, pt reported that her LEFT arm was warm, had a red rash, and tender to palpation. Pt also stated that she felt as if her throat were closing.
LMP 6-14-17; EDD 3-11-18. Patient was approximately 15 weeks 2 days gestation at time of vaccine administration.
Covid 19 Pfizer Gray Top was diluted with 1.8 ml of diluent in error. Patient received diluted dose
pt vax hepta B. 3 weeks later pt devel. flu-like illness w/ elevated transaminases and jaundice.  An MD diagnosed problem as hepatitis.  Bloodwork for hepta A and B negative.
This spontaneous report as received from a physician via company representative refers to a patient of unknown age and gender. No medical history and current conditions were reported. On an unknown date the patient was vaccinated with GARDASIL (dose, lot number was unknown) after the age of 26 years old. No adverse effects were reported. No product quality complaint was involved. The outcome of the events was unknown. No further information was provided. Additional information has been requested.
itching around his waist; spider bite; the spot on his waist looked like shingles; spot was a circle that turned black, and had a lot of dark spots, like bruises around the black circle; spot was a circle that turned black, and had a lot of dark spots, like bruises around the black circle; This is a spontaneous report from a contactable consumer. This consumer reported events for two doses. This is the first of two doses.  A 66-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247), intramuscular, administered in the left arm, on 16Jan2021 at a single dose (at the age of 66-years-old) for COVID-19 immunisation. The patient had no medical history and no concomitant medication. The patient had "no problem" with his first COVID-19 shot.  A week after his first COVID-19 vaccine dose, he had itching around his waist. He thought he may have had a spider bite, because he had been working around an area that had hatched black widow spider eggs. While he was at an appointment with his urologist, his urologist said the spot on his waist looked like shingles. He had 1 spot on his waist. The spot was a circle that turned black, and had a lot of dark spots, like bruises around the black circle. He was putting on cream on the spot on his waist and has gone away slowly. His blood work was "OK, and there was nothing negative". The patient was recovering from the events.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021194671 Same patient, same drug with different vaccine dose, different AE
Fever of 101.8 for 24 hours followed by asthma/coughing attacks (3 over the next 12 hours), joint pain, and very large red rash around injection site that was hot to the touch and hardened feeling under the skin. Currently on day 3 post vaccine and rash continues to grow larger at this time.
Fever and body aches started day after injection, last for 2 days, third morning woke up with rash to both arms. Taking tylenol and benadryl.
Pt recvd Hep B vax in 1986 & on the same day as inject pt exp SOB & devel redness, itching & burning @ inject site; It was noted that exp necessitated a visit to either an ER or MD office;
Occasional hives; Several scars where I scratched; rash on thigh, abdomen and arm; (rash) terribly itchy; raised blisters after scratching the itchy sites; Itchiness around the clock; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC ((rash) terribly itchy), BLISTER (raised blisters after scratching the itchy sites), URTICARIA (Occasional hives), PRURITUS (Itchiness around the clock) and SCAR (Several scars where I scratched) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Pollen allergy, Oral allergy syndrome and Psoriasis. Concomitant products included COLECALCIFEROL (VIT D3) for an unknown indication.   On 26-Feb-2021 at 12:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 02-Mar-2021, the patient experienced RASH PRURITIC ((rash) terribly itchy), BLISTER (raised blisters after scratching the itchy sites) and RASH (rash on thigh, abdomen and arm). On an unknown date, the patient experienced URTICARIA (Occasional hives), PRURITUS (Itchiness around the clock) and SCAR (Several scars where I scratched). The patient was treated with CORTISONE for Itchy, at an unspecified dose and frequency. At the time of the report, RASH PRURITIC ((rash) terribly itchy), BLISTER (raised blisters after scratching the itchy sites), URTICARIA (Occasional hives), PRURITUS (Itchiness around the clock), SCAR (Several scars where I scratched) and RASH (rash on thigh, abdomen and arm) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment included cortisone cream on the rash which helped relieve itchiness.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Updated all events outcome from unknown to recovering/resolving and duration for events rash, rash pruritic and blister and first dose information.Added new events urticaria, scar and pruritic and concomitant medication, medical history and second dose information.
Patient reports having hives to right hand and lower arm. No itching. Reports symptoms got better and cleared by EMS
This spontaneous report as received from a pharmacist refers to a 60-year-old female patient. The patient's medical history included shingles (date reported as prior to ZOSTAVAX). There was no concurrent condition reported. There were any drug reaction and allergies. On 15-MAR-2015 the patient was vaccinated with ZOSTAVAX lot # K016320, 0.65 ml, expiration date 24-DEC-2015. The pharmacist stated that she was unsure if ZOSTAVAX was administered subcutaneously, because the injection site is located on the "inner part of the patient's unspecified arm". Concomitant therapies included spironolactone 50 mg. On 15-MAR-2015, "that night" that the patient received ZOSTAVAX, she developed "hot" at the injection side. On 17-MAR-2015 the patient experienced itchiness at the injection site and the itchiness was worse at the next day. The patient sought medical attention. On 18-MAR-2015 the patient went into the pharmacy and informed the pharmacist of her symptoms. The pharmacist informed the patient to apply over the counter hydrocortisone cream (manufacturer unspecified) to the injection side and to take ibuprofen as needed. The outcome of the events was reported as not recovered. The relatedness between the events and ZOSTAVAX was not reported. Additional information has been requested.
Information has been received from a health professional concerning an 8 week old male who was entered in a study. In approximately 2007, the patient was vaccinated PO with the first dose of ROTATEQ. It was reported that 21 days post-vaccination, the patient presented with dark bloody stools and crampy abdominal pain. The patient was hospitalized and referred for a surgical evaluation to rule out intussusception. An air enema revealed an ileocolic intussusception which was reduced. The patient was discharged "well" on "day 2". The reporting investigator considered intussusception to be an other important medical event. No further information is available.